EUVIMEDEUVIMED entdecken
Leserbrief

Haemodynamic effects of fludrocortisone and midodrine in patients with symptoms due to hypotension

Frederik J de Lange, Steven van Zanten, Giulia Rivasi, Antonella Groppelli, Vincenzo Russo, Roberto Maggi, Marco Capacci, Sara Nawaz, Angelo Comune, Andrea Ungar, Gianfranco Parati, Michele Brignole und 1 weitere

Clinical Autonomic Research · 2025

DOI: 10.1007/s10286-024-01096-3 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Autonomic Research, 2025. Verfasst von Frederik J de Lange und 12 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Centre, University of Amsterdam, Meibergd…. Hauptthemen laut MEDLINE: Fludrocortisone, Midodrine, Hypotension, Hemodynamics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Agenzia Italiana del Farmaco, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: The study aimed to assess the haemodynamic effects of fludrocortisone and midodrine, alone or combined, in patients with recurrent syncope and/or symptoms due to hypotension and ≥ 1 daytime systolic blood pressure (SBP) drop < 90 mmHg or ≥ 2 daytime SBP drops < 100 mmHg recorded by 24-h ambulatory blood pressure monitoring (ABPM1). METHOD: A total of 53 patients (mean age, 40.9 ± 18.5 years, 37 female) were treated with fludrocortisone (0.05-0.2 mg per day) and/or midodrine (2.5-10 mg two or three times per day). A second ABPM (ABPM2) was performed within 6 months and the results of ABPM1 AND ABPM2 were compared to assess the effects of BP-rising drugs. RESULTS: In 32 patients assigned to fludrocortisone, 24-h SBP increased from 107.1 ± 9.9 mmHg to 116.3 ± 14.9 (p = 0.0001), the number of daily SBP drops < 90 mmHg decreased by 73% (p = 0.0001) and that of drops < 100 mmHg decreased by 41% (p = 0.0005). In 14 patients assigned to midodrine, 24-h SBP increased from 112.7 ± 7.4 mmHg to 115.0 ± 9.1 (p = 0.12), the number of daily SBP drops < 90 mmHg decreased by 52% (p = 0.04) and that of drops < 100 mmHg decreased by 34% (p = 0.007). In the seven patients taking both fludrocortisone and midodrine, 24-h SBP increased from 110.1 ± 11.5 mmHg to 114.0 ± 12.4 (p = 0.002), the number of daily SBP drops < 90 mmHg decreased by 69% (p = 0.22) and that of drops < 100 mmHg decreased by 44% (p = 0.04). CONCLUSIONS: Both fludrocortisone and midodrine effectively increased 24-h SBP and reduced SBP drops on ABPM but fludrocortisone seemed to be more effective than midodrine. Further randomised studies are needed to confirm these observations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FludrocortisoneMidodrineHypotensionHemodynamicsHumansFemaleMaleMiddle AgedAdultBlood PressureBlood Pressure Monitoring, AmbulatoryAgedYoung Adult

Stichwörter der Autor:innen

24-h ambulatory blood pressure monitoringBlood pressure-rising drugsHypotensionReflex syncope

Substanzen

FludrocortisoneMidodrine

Autor:innen und Institutionen

  • Amsterdam UMC, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Centre, University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
  • Reinier de Graaf Gasthuis, Department of Cardiology, Cardiology and Syncope Unit, Reinier de Graafweg 5, 2625 AD, Delft, The Netherlands.
  • Division of Geriatric and Intensive Care Medicine, University of Florence and Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
  • Faint and Fall Research Centre, Department of Cardiology, IRCCS Istituto Auxologico Italiano, S. Luca Hospital, Piazzale Brescia 20, 20149, Milano, Italy.
  • Cardiology and Syncope Unit, Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli'-Monaldi Hospital, Piazzale E. Ruggeri, 80126, Naples, Italy.
  • Department of Cardiology, Ospedali del Tigullio, Lavagna, Italy.

Förderung

  • Agenzia Italiana del Farmaco, Ministero della Salute

Zitieren

APA

de Lange, F. J., van Zanten, S., Rivasi, G., Groppelli, A., Russo, V., Maggi, R., Capacci, M., Nawaz, S., Comune, A., Ungar, A., Parati, G., Brignole, M., & Fedorowski, A. (2025). Haemodynamic effects of fludrocortisone and midodrine in patients with symptoms due to hypotension. Clinical Autonomic Research. https://doi.org/10.1007/s10286-024-01096-3

Vancouver

de Lange FJ, van Zanten S, Rivasi G, Groppelli A, Russo V, Maggi R, et al. Haemodynamic effects of fludrocortisone and midodrine in patients with symptoms due to hypotension. Clinical Autonomic Research. 2025. doi:10.1007/s10286-024-01096-3

BibTeX
@article{deLange2025,
  author = {de Lange, Frederik J and van Zanten, Steven and Rivasi, Giulia and Groppelli, Antonella and Russo, Vincenzo and Maggi, Roberto and Capacci, Marco and Nawaz, Sara and Comune, Angelo and Ungar, Andrea and Parati, Gianfranco and Brignole, Michele and Fedorowski, Artur},
  title = {Haemodynamic effects of fludrocortisone and midodrine in patients with symptoms due to hypotension},
  journal = {Clinical Autonomic Research},
  year = {2025},
  doi = {10.1007/s10286-024-01096-3}
}
Kostenlos starten →